Abstract:The deposition of beta-amyloid (A beta) plaques in the parenchymal and cortical brain is accepted as the main pathological hallmark of Alzheimer's disease (AD); however, early detection of AD still presents a challenge. With the assistance of molecular imaging techniques, imaging agents specifically targeting A beta plaques in the brain may lead to the early diagnosis of AD. Herein, we report the design, synthesis, and evaluation of a series of smart near-infrared fluorescence (NIRF) imaging probes with donor acceptor architecture bridged by a conjugated pi-electron chain for A beta plaques. The chemical structure of these NIRF probes is completely different from Congo Red and Thioflavin-T. Probes with a longer conjugated pi system (carbon carbon double bond) displayed maximum emission in PBS (>650 nm), which falls in the best range for NIRF probes. These probes were proved to have affinity to A beta plaques in fluorescent staining of brain sections from an AD patient and double transgenic mice, as well as in an in vitro binding assay using A beta(1-42) aggregates. One probe with high affinity (k(i) = 37 nM, K-d = 27 nM) was selected for in vivo imaging. It can penetrate the blood-brain barrier of nude mice efficiently and is quickly washed out of the normal brain. Moreover, after intravenous injection of this probe, 22-month-old APPswe/PSENI mice exhibited a higher relative signal than control mice over the same period of time, and ex vivo fluorescent observations confirmed the existence of A beta plaques. In summary, this probe meets most of the requirements for a NIRF contrast agent for the detection of A beta plaques both in vitro and in vivo.

Progress of Near-Infrared Fluorescent Probes for beta-Amyloid Plaques in the Brain

Near-infrared Fluorescent Probes for Imaging of Amyloid Plaques in Alzheimer׳s Disease.

Smart Near-Infrared Fluorescence Probes with Donor–Acceptor Structure for in Vivo Detection of Β-Amyloid Deposits

Targeting Β-Amyloid Plaques and Oligomers: Development of Near-Ir Fluorescence Imaging Probes.

Fluorescent Imaging of Amyloid-β Deposits in Brain: An Overview of Probe Development and a Highlight of the Applications for in vivo Imaging.

Amyloid-β Deposits Target Efficient Near-Infrared Fluorescent Probes: Synthesis, in Vitro Evaluation and in Vivo Imaging.

Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer’s Disease

Development of Near-Infrared Fluorescent Probes for Use in Alzheimer’s Disease Diagnosis

Development of Near-Infrared Fluorescent Probes for Use in Alzheimers Disease Diagnosis

Near-Infrared Fluorescent Probes with Rotatable Polyacetylene Chains for the Detection of Amyloid-β Plaques

Advances in development of fluorescent probes for detecting amyloid-β aggregates

Environment-Sensitive Near-Infrared Probe for Fluorescent Discrimination of Aβ and Tau Fibrils in AD Brain.

Near-Infrared Fluorescent Probes As Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer’s Disease

Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease

In Vivo Near-Infrared Fluorescence Imaging of Amyloid-Β Plaques with a Dicyanoisophorone-Based Probe.

Rational Design of Near-Infrared Aggregation-Induced-Emission-Active Probes: in Situ Mapping of Amyloid-β Plaques with Ultrasensitivity and High-Fidelity.

Iterative Design of Near-Infrared Fluorescent Probes for Early Diagnosis of Alzheimer's Disease by Targeting Aβ Oligomers

Past And Recent Progress Of Molecular Imaging Probes For Beta-Amyloid Plaques In The Brain

Evaluation of N, O-Benzamide Difluoroboron Derivatives As Near-Infrared Fluorescent Probes to Detect Β-Amyloid and Tau Tangles.

Near-Infrared Aggregation-Induced Emission Luminogens for In Vivo Theranostics of Alzheimer's Disease.

Development of Novel Near-Infrared GFP Chromophore-Based Fluorescent Probes for Imaging of Amyloid-Β Plaque and Viscosity